Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
  1. 4 Grant or award President and CEO acquired 12,681 shares (grant or award)
  2. 4 Open-market buy Director bought 10,000 shares at $1.41 ($14,100)
  3. 4 Grant or award President and CEO acquired 10,802 shares (grant or award)
  4. 4/A Grant or award President and CEO acquired 10,736 shares (grant or award)
  5. 4 Grant or award President and CEO acquired 10,736 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 9,777 shares (grant or award)
  7. 4 Grant or award President and CEO acquired 9,211 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 8,028 shares (grant or award)
  9. 4/A Open-market sale 10% owner sold 10,000 shares at $2.09 ($20,870)
  10. 4 Open-market sale 10% owner sold 10,000 shares at $2.09 ($20,870)
  11. 4/A Grant or award President and CEO acquired 7,743 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 10,606 shares (grant or award)
  13. 4 Open-market buy Director bought 5,000 shares at $2.50 ($12,500)
  14. 4 Grant or award President and CEO acquired 10,606 shares (grant or award)
  15. 4 Grant or award President and CEO acquired 13,359 shares (grant or award)
  16. 4 Grant or award President and CEO acquired 13,780 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 13,566 shares (grant or award)
  18. 4 Open-market buy Director bought 5,000 shares at $1.33 ($6,650)
  19. 4 Grant or award President and CEO acquired 12,868 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 11,290 shares (grant or award)

Page 9 of 39 · 776 filings